PVLA
Palvella Therapeutics, Inc
130.60$
+2.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -93.3% | -95.9% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -93.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -53.6% | -77.9% | +46.5% | +121.6% | -20.4% | +60.2% | +25.6% | +27.5% | +9.1% | +31.1% | +33.6% | – | |
| – | – | – | +89.2% | +28.2% | -3.0% | +108.3% | +8.8% | -11.7% | +14.6% | +32.0% | +61.8% | – | |
| – | -56.8% | -74.1% | +65.3% | +74.1% | -13.7% | +80.3% | +17.5% | +10.0% | +11.1% | +31.4% | +44.1% | – | |
| – | -277.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +31.3% | +17.0% | +5.4% | -6.8% | +11.4% | +11.5% | +15.2% | +17.3% | +13.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -3,309.1% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.